α1L-adrenoceptors mediate contraction of human erectile tissue

α1-adrenoceptor antagonists can impact upon sexual function and have potential in the treatment of erectile dysfunction. Human erectile tissue contains predominantly α1A-adrenoceptors, and here we examined whether contractions of this tissue are mediated by the functional phenotype, the α1L-adrenoce...

Full description

Saved in:
Bibliographic Details
Main Authors: Beverley J. Davis (Author), Christopher R. Chapple (Author), Donna J. Sellers (Author), Alisdair L. Naylor (Author), David Sillar (Author), Alistair Campbell (Author), Russ Chess-Williams (Author)
Format: Book
Published: Elsevier, 2018-08-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_a2e5779efeef4de4baf1c91db8a1661d
042 |a dc 
100 1 0 |a Beverley J. Davis  |e author 
700 1 0 |a Christopher R. Chapple  |e author 
700 1 0 |a Donna J. Sellers  |e author 
700 1 0 |a Alisdair L. Naylor  |e author 
700 1 0 |a David Sillar  |e author 
700 1 0 |a Alistair Campbell  |e author 
700 1 0 |a Russ Chess-Williams  |e author 
245 0 0 |a α1L-adrenoceptors mediate contraction of human erectile tissue 
260 |b Elsevier,   |c 2018-08-01T00:00:00Z. 
500 |a 1347-8613 
500 |a 10.1016/j.jphs.2018.08.003 
520 |a α1-adrenoceptor antagonists can impact upon sexual function and have potential in the treatment of erectile dysfunction. Human erectile tissue contains predominantly α1A-adrenoceptors, and here we examined whether contractions of this tissue are mediated by the functional phenotype, the α1L-adrenoceptor. Functional experiments using subtype selective agonists and antagonists, along with radioligand ([3H]tamsulosin) binding assays, were used to determine the α1-adrenoceptor population. A61603, a α1A-adrenoceptor agonist, was a full agonist with a potency 21-fold greater than that of noradrenaline. The α1A- and α1D-adrenoceptor antagonist tamsulosin antagonized noradrenaline responses with high affinity (pKD = 9.7 ± 0.3), whilst BMY7378 (100 nM) (α1D-adrenoceptor antagonist) failed to antagonize responses. In contrast, relatively low affinity estimates were obtained for both prazosin (pKD = 8.2 ± 0.1) and RS17053 (pKD = 6.9 ± 0.2), antagonists which discriminate between the α1A- and α1L-adrenoceptors. [3H]Tamsulosin bound with high affinity to the receptors of human erectile tissue (pKD = 10.3 ± 0.1) with a receptor density of 28.1 ± 1.4 fmol mg−1 protein. Prazosin displacement of [3H]tamsulosin binding revealed a single homogenous population of binding sites with a relatively low affinity for prazosin (pKi = 8.9). Taken together these data confirm that the receptor mediating contraction in human erectile tissue has the pharmacological properties of the α1L-adrenoceptor. Keywords: Erectile tissue, α1-adrenoceptor subtypes, α1L-adrenoceptor, Tamsulosin, Prazosin 
546 |a EN 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Journal of Pharmacological Sciences, Vol 137, Iss 4, Pp 366-371 (2018) 
787 0 |n http://www.sciencedirect.com/science/article/pii/S1347861318301348 
787 0 |n https://doaj.org/toc/1347-8613 
856 4 1 |u https://doaj.org/article/a2e5779efeef4de4baf1c91db8a1661d  |z Connect to this object online.